Xinbin Chen Selected Research

Iron Regulatory Protein 2

1/2020	Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.
1/2019	Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.
1/2017	Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinbin Chen Research Topics

Disease

62	Neoplasms (Cancer) 01/2022 - 01/2002
7	Carcinogenesis 11/2019 - 08/2008
6	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2005
4	Inflammation (Inflammations) 10/2021 - 01/2010
4	Breast Neoplasms (Breast Cancer) 10/2019 - 10/2007
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 11/2002
3	Acute Promyelocytic Leukemia 01/2014 - 05/2011
3	Xeroderma Pigmentosum (Kaposi's Disease) 02/2012 - 02/2006
2	Iron Overload 01/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 08/2013 - 05/2009
2	Carcinoma (Carcinomatosis) 01/2010 - 08/2003
1	Pulmonary Tuberculosis 01/2022
1	Diabetes Mellitus 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Glioma (Gliomas) 12/2021
1	Fatty Liver 10/2021
1	Triple Negative Breast Neoplasms 10/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Iron Deficiencies 01/2019
1	Hemochromatosis (Bronze Diabetes) 01/2019
1	Anemia 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Hypoxia (Hypoxemia) 11/2018
1	Shock 03/2013

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2005
7	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 01/2012
6	Protein Isoforms (Isoforms)IBA 01/2022 - 03/2006
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 02/2010
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2005
4	IronIBA 01/2020 - 01/2017
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2010
4	Biological ProductsIBA 10/2017 - 08/2008
4	Transcription Factors (Transcription Factor)IBA 01/2013 - 01/2003
3	Peptides (Polypeptides)IBA 01/2022 - 01/2019
3	CytokinesIBA 12/2021 - 08/2012
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2012
3	Iron Regulatory Protein 2IBA 01/2020 - 01/2017
3	Arsenic Trioxide (Trisenox)FDA Link 01/2014 - 05/2011
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2014 - 10/2011
3	Histone Deacetylase InhibitorsIBA 01/2014 - 04/2007
3	Rad30 proteinIBA 02/2012 - 02/2006
3	Tetracycline (Achromycin)FDA LinkGeneric 08/2003 - 10/2002
2	Ferredoxins (Ferredoxin)IBA 01/2022 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2017
2	SurvivinIBA 01/2021 - 08/2012
2	Estrogen ReceptorsIBA 10/2019 - 08/2012
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 11/2002
2	ChromatinIBA 11/2016 - 08/2012
2	Poly CIBA 03/2016 - 01/2011
2	Carrier Proteins (Binding Protein)IBA 03/2016 - 01/2011
2	UbiquitinIBA 03/2016 - 05/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2013 - 04/2007
2	Small Interfering RNA (siRNA)IBA 03/2013 - 10/2010
2	ArsenicIBA 02/2013 - 05/2011
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 02/2012 - 02/2006
2	myosin VIIBA 08/2010 - 03/2006
2	Glycogen Synthase Kinase 3 betaIBA 12/2003 - 06/2002
1	AcidsIBA 01/2022
1	Coenzymes (Enzyme Cofactors)IBA 01/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	Eukaryotic Initiation Factor-4EIBA 01/2022
1	EnzymesIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	olaparibIBA 01/2022
1	LipidsIBA 01/2022
1	Thiamine (Aneurin)FDA Link 01/2022
1	olfactomedinIBA 12/2021
1	Glycoproteins (Glycoprotein)IBA 12/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2021
1	Conditioned Culture MediaIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Cornified Envelope Proline-Rich ProteinsIBA 06/2021
1	sepantroniumIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2019
1	CholesterolIBA 10/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019
1	3' Untranslated Regions (3' UTR)IBA 01/2019
1	PlatinumIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	ClusterinIBA 11/2018
1	Basic Helix-Loop-Helix Transcription FactorsIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 11/2016
1	TIC10 compoundIBA 11/2016
1	AntibodiesIBA 11/2016
1	Death Domain ReceptorsIBA 11/2016
1	Ligases (Synthetase)IBA 03/2016
1	Docetaxel (Taxotere)FDA Link 03/2013
1	Cyclin-Dependent Kinase Inhibitor p21IBA 10/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 08/2012
1	Tamoxifen FDA LinkGeneric 08/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Cyclin DIBA 08/2012
1	Interleukin-8 (Interleukin 8)IBA 08/2012

Therapy/Procedure

13	Therapeutics 11/2019 - 03/2005
4	Castration 03/2013 - 01/2012
1	Radiotherapy 01/2022
1	Precision Medicine 01/2022